NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells

par Di Matteo, P, Hackl, C, Jedeszko, C, Valentinis, B, Bordignon, C, Traversari, C, Kerbel, R S, Rizzardi, G-P
Publié 2013

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

par Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Publié dans Leukemia (2016)